
Dx Deals: QuidelOrtho Acquires LEX Diagnostics, Plans to Switch Out Respiratory Testing Platforms
The $100 million deal will take advantage of LEX VELO technology to detect influenza and SARS-CoV-2

The $100 million deal will take advantage of LEX VELO technology to detect influenza and SARS-CoV-2

The company is offering whole panels and more than 1,000 assays in total to support the new products

The PCR-driven test provides results in about 20 minutes in non-laboratory settings

In vitro diagnostic products approved by the U.S. Food and Drug Administration in 2024 show a continued move toward rapid and point-of-care tests

Several years after the onset of the COVID-19 pandemic, labs are still dealing with the effects of missed and delayed screenings